A contrarian view of malaria therapy policy in Africa

American Journal of Tropical Medicine and Hygiene

Volumn 68, Issue 2, 2003, Pages 125-126

  Bloland, Peter B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISININ; CHLOROQUINE; FANSIDAR; MEFLOQUINE; ARTEMISIN; ARTEMISININ DERIVATIVE; LACTONE; SESQUITERPENE;

AFRICA; ARTEMISIA ANNUA; COMBINATION CHEMOTHERAPY; COST OF ILLNESS; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG USE; EDITORIAL; HEALTH CARE POLICY; HUMAN; MALARIA; MONOTHERAPY; WORLD HEALTH ORGANIZATION; AFRICA SOUTH OF THE SAHARA; DRUG COMBINATION; MALARIA FALCIPARUM; NOTE;

ARTEMISIA; ARTEMISIA ANNUA;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; ARTEMISININS; DRUG THERAPY, COMBINATION; HEALTH POLICY; HUMANS; LACTONES; MALARIA, FALCIPARUM; SESQUITERPENES;

EID: 0037313725     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2003.68.125     Document Type: Editorial

References (12)

1. WHO, 2001. Antimalarial drug combination therapy. Report of a WHO Technical Consultation, 4-5 April 2001. WHO/CDS/RBM/2001.35. Geneva: World Health Organization.
2. Baker L, Barnes K, 2001. New antimalarial treatment for Kwa-Zulu Natal. S Afr Med J 91: 358-359.
3. White NJ, 1998. Preventing antimalarial drug resistance through combinations. Drug Resistance Updates 1: 3-9.
4. Bloland PB, Ettling M, Meek S, 2000. Combination therapy for malaria in Africa: Hype or hope? Bulletin of the World Health Organization 78: 1378-1388.
5. Ettling MB, 2002. The control of Malaria in Viet Nam from 1980 to 2000: What went right? Report of Consultancy for World Health Organization Regional Office for the Western Pacific, Manila.
6. Nosten F, Hien TT, White NJ, 1998. Use of artemisinin derivatives for the control of malaria. Médecine Tropicale 58 (suppl 3): 45-49.
7. Gasasira AF, Dorsey G, Nzarubara B, Staedke SG, Nassali A, Rosenthal PJ, Kamya MR, 2003. Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Am J Trop Med Hyg 68: 127-132.
8. Kapp C, 2002. Global Fund faces uncertain future as cash runs low. Lancet 360: 1225.
9. Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui PB, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WR, 2002. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359: 1365-1372.
10. Basco LK, Same-Ekobo A, Ngane VF, Ndounga M, Metoh T, Ringwald P, Soula G, 2002. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodia-quine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bulletin of the World Health Organization 80: 538-545.
11. Dorsey G, Njama D, Kamya MR, Cattamanchi A, Kyabayinze D, Staedke SG, Gasasira A, Rosenthal PJ, 2002. Sulfadoxine/ pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet 360: 2031-2038.
12. Staedke SG, Kamya MR, Dorsey G, Gasasira A, Ndeezi G, Charlebois ED, Rosenthal PJ, 2001. Amodiaquine, sulfadoxine/ pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet 358: 368-374.